Inhibition of Stress-Inducible Kinase Pathways by Tumorigenic Mutant p53
More than 50% of human cancers contain p53 gene mutations and as a result accumulate altered forms of the full-length p53 protein. Although certain tumor types expressing mutant p53 protein have a poor prognostic process, the precise role of mutant p53 protein in highly malignant tumor cells is not...
Tallennettuna:
| Julkaisussa: | Mol Cell Biol |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Taylor & Francis
2003
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC140653/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12482984/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/MCB.23.1.322-334.2003 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|
